Pharma's Almanac TV
PA TV
Follow the Completed Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Follow the Completed Journey
Companies On The Road
Follow The Artist
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Dashboard
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
2021 Cell & Gene Therapy Report
2021 Monoclonal Antibody & Recombinant Protein Market Report
2022 Sterile Drug Market Report
2022 API Market Report
2020 OSD Market Report
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
More+
Staffing
Media Kit
Biologics
170 Articles Available
1
8
Can't find what you're looking for? Try our
advanced search
.
Data Connectivity
Discussing the Advancements in Oncology
PATV-12-21-01
Strategic Alliance
FUJIFILM Cellular Dynamics and PhenoVista Biosciences Announce Strategic Alliance to Improve the Drug Discovery Process
PR-M01-22-05
Biologics
An Evolving Biologics Landscape and Driving Innovation and Opportunity
PAO-11-21-CL-16
Formulation
Accelerating Biologics Development with High-Quality Protein Stabilization Excipients
PAO-11-21-CL-12
Vaccines
IDT Biologika Celebrates 100 Years of Successful Vaccine Development and U.S. Expansion
PAO-10-21-CL-07
Expansion
Olon Announces A Strategic Expansion to Produce Proteins with an Advanced and Sustainable Approach
PR-M09-21-02
Biologics
The BioAnalytix Lab in Cambridge, MA
PTV-07-21-CL-002
Quality
Strong Quality Systems and Quality Culture Ensure Inspection-Ready Status
PAO-06-21-CL-12
Collaboration
Collaboration in Action: New Milestones Efficiency and Simplifying the Complexities of Drug Development
PAO-06-21-CL-02
Capacity Expansion
German CDMO Richter-Helm Triples cGMP Production Capacity to Accommodate Global Market Demand
PR-M05-21-008
Pyxis Oncology Closes $152 Million Series B Financing to Further Advance Portfolio of Biologics
PR-M04-21-001
Nu-Tek BioSciences to Build Dedicated Animal-free Peptone Manufacturing Facility to service Growing Biologics Supply Chain Demands
PR-M11-20-043
Single-Use Technology
Stainless Steel to Single-Use: How to Adapt to the Changing Landscape in SUT
PAP-Q4-20-CL-004
The Future of Healthcare
How Does Polpharma Biologics Envision the Future of the Pharma/Biopharma Industry?
PAP-Q4-20-RT2-010
Licensing
ProteoNic Announces Licensing of its 2G UNic™ Technology Platform for Production of Biologics to Gilead Sciences
PR-M11-20-004
Leadership
A CEO’s Perspective: Positioning a CDMO for Significant Growth
PAP-Q3-20-CL-008
Clinical Supply
Getting Your Biologic to Clinic Faster and More Efficiently
PAP-Q3-20-CL-011
Nice Insight Overview
Drug Approval Trends: Significant Acceleration in Recent Years
PAP-Q2-20-NI-001
GSK's Asthma Biologic Approved
PR-M04-20-NI-007
Facility
WuXi Biologics Completes Weather-Tight Seal of its Biologics Manufacturing Facility in Ireland
PR-M03-20-NI-019
Biologics
FDA and FTC Announce New Efforts to Further Deter Anti-Competitive Business Practices, Support Competitive Market for Biological Products
PR-M02-20-NI-016
Analytical Development
Solving Process Challenges Requires Flexibility to Explore Alternative Analytical Methods
PAP-Q4-19-CL-017
Bispecific Antibody
Challenges of Manufacturing the Expanding Range of Bi/Multispecific Modalities
PAP-Q4-19-CL-022
Strategic Partnership
Partnering for Success from Concept to Commercialization
PAP-Q4-19-CL-010
1
8
»
